TCDA - Tricida - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

134.7M

Cash

0.00

Avg Qtr Burn

N/A

Short % of Float

31.33%

Insider Ownership

8.01%

Institutional Own.

64.72%

Qtr Updated

09/30/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Veverimer (TRC101) Details Chronic kidney disease, Kidney disease	NDA Resubmission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Veverimer (TRC101) Details Chronic kidney disease, Kidney disease	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.